DUPONT Pharmaceuticals.(signs agreement with Barr Laboratories)(Brief Article)

Chemical Market Reporter, March, 2000

DUPONT Pharmaceuticals and Barr Lab-oratories have signed a development and marketing agreement under which DuPont will invest up to $45 million to support the development of three Barr products. DuPont was also granted warrants to purchase 1 million shares of Barr's stock.

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
Click Here
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement
Click Here